Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for progression of visual field damage in primary open-angle glaucoma
jRCTs051240159Recruiting
- Sponsor
- Japan Society for the Promotion of Science
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of metformin in open-angle glaucoma (OAG), sponsored by Japan Society for the Promotion of Science. Primary endpoint: Annual rate of change in mean deviation on Humphrey visual field test. Started Dec 2024; status: recruiting.
02
Drugs
metformin
03
Conditions
open-angle glaucoma (OAG)
Beyond the preview
Go deeper on jRCTs051240159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051240159.